• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腔面型乳腺癌细胞的核重编程产生 Sox2 过表达的癌症干细胞样细胞状态,其特征是 mTOR 通路的转录激活。

Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.

机构信息

Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Girona, Spain; Molecular Oncology; Girona Biomedical Research Institute (IDIBGI); Girona, Spain.

出版信息

Cell Cycle. 2013 Sep 15;12(18):3109-24. doi: 10.4161/cc.26173. Epub 2013 Aug 21.

DOI:10.4161/cc.26173
PMID:23974095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3875684/
Abstract

Energy metabolism plasticity enables stemness programs during the reprogramming of somatic cells to an induced pluripotent stem cell (iPSC) state. This relationship may introduce a new era in the understanding of Warburg's theory on the metabolic origin of cancer at the level of cancer stem cells (CSCs). Here, we used Yamanaka's stem cell technology in an attempt to create stable CSC research lines in which to dissect the transcriptional control of mTOR--the master switch of cellular catabolism and anabolism--in CSC-like states. The rare colonies with iPSC-like morphology, obtained following the viral transduction of the Oct4, Sox2, Klf4, and c-Myc (OSKM) stemness factors into MCF-7 luminal-like breast cancer cells (MCF-7/Rep), demonstrated an intermediate state between cancer cells and bona fide iPSCs. MCF-7/Rep cells notably overexpressed SOX2 and stage-specific embryonic antigen (SSEA)-4 proteins; however, other stemness-related markers (OCT4, NANOG, SSEA-1, TRA-1-60, and TRA-1-81) were found at low to moderate levels. The transcriptional analyses of OSKM factors confirmed the strong but unique reactivation of the endogenous Sox2 stemness gene accompanied by the silencing of the exogenous Sox2 transgene in MCF-7/Rep cells. Some but not all MCF-7/Rep cells acquired strong alkaline phosphatase (AP) activity compared with MCF-7 parental cells. SOX2-overexpressing MCF-7/Rep cells contained drastically higher percentages of CD44(+) and ALDEFLUOR-stained ALDH(bright) cells than MCF-7 parental cells. The overlap between differentially expressed mTOR signaling-related genes in 3 different SOX2-overexpressing CSC-like cell lines revealed a notable downregulation of 3 genes, PRKAA1 (which codes for the catalytic α 1 subunit of AMPK), DDIT4/REDD1 (a stress response gene that operates as a negative regulator of mTOR), and DEPTOR (a naturally occurring endogenous inhibitor of mTOR activity). The insulin-receptor gene (INSR) was differentially upregulated in MCF-7/Rep cells. Consistent with the downregulation of AMPK expression, immunoblotting procedures confirmed upregulation of p70S6K and increased phosphorylation of mTOR in Sox2-overexpressing CSC-like cell populations. Using an in vitro model of the de novo generation of CSC-like states through the nuclear reprogramming of an established breast cancer cell line, we reveal that the transcriptional suppression of mTOR repressors is an intrinsic process occurring during the acquisition of CSC-like properties by differentiated populations of luminal-like breast cancer cells. This approach may provide a new path for obtaining information about preventing the appearance of CSCs through the modulation of the AMPK/mTOR pathway.

摘要

能量代谢可塑性使体细胞在重编程为诱导多能干细胞(iPSC)状态时的干性程序成为可能。这种关系可能会在理解癌症干细胞(CSC)水平上沃伯格(Warburg)关于癌症代谢起源的理论方面引入一个新的时代。在这里,我们使用山中伸弥(Yamanaka)的干细胞技术,试图在其中创建稳定的 CSC 研究线,以剖析 mTOR 的转录控制-细胞分解代谢和合成代谢的主开关-在 CSC 样状态下。通过病毒转导将 Oct4、Sox2、Klf4 和 c-Myc(OSKM)干性因子转入 MCF-7 腔上皮样乳腺癌细胞(MCF-7/Rep)后,获得了具有 iPSC 样形态的稀有菌落,这些菌落表现出癌细胞与真正的 iPSC 之间的中间状态。MCF-7/Rep 细胞显著过表达 SOX2 和阶段特异性胚胎抗原(SSEA)-4 蛋白;然而,其他与干性相关的标记物(OCT4、NANOG、SSEA-1、TRA-1-60 和 TRA-1-81)的水平较低。OSKM 因子的转录分析证实了内源 Sox2 干性基因的强烈但独特的再激活,同时伴随着 MCF-7/Rep 细胞中外源 Sox2 转基因的沉默。与 MCF-7 亲本细胞相比,一些但不是所有 MCF-7/Rep 细胞均获得了较强的碱性磷酸酶(AP)活性。与 MCF-7 亲本细胞相比,过表达 SOX2 的 MCF-7/Rep 细胞中 CD44(+)和 ALDEFLUOR 染色的 ALDH(bright)细胞的比例明显更高。在 3 种不同的 SOX2 过表达 CSC 样细胞系中差异表达的 mTOR 信号相关基因的重叠表明,有 3 个基因的表达明显下调,PRKAA1(编码 AMPK 的催化α1亚基),DDIT4/REDD1(一种应激反应基因,作为 mTOR 的负调节剂)和 DEPTOR(一种天然存在的 mTOR 活性内源性抑制剂)。胰岛素受体基因(INSR)在 MCF-7/Rep 细胞中差异上调。与 AMPK 表达下调一致,免疫印迹程序证实,在 SOX2 过表达的 CSC 样细胞群中,p70S6K 的表达上调和 mTOR 的磷酸化增加。通过核重编程建立的乳腺癌细胞系,我们在体外建立了 CSC 样状态的从头生成模型,揭示了 mTOR 抑制剂的转录抑制是在腔上皮样乳腺癌细胞分化群体获得 CSC 样特性时发生的内在过程。这种方法可能为通过调节 AMPK/mTOR 途径获得有关预防 CSC 出现的信息提供新途径。

相似文献

1
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.腔面型乳腺癌细胞的核重编程产生 Sox2 过表达的癌症干细胞样细胞状态,其特征是 mTOR 通路的转录激活。
Cell Cycle. 2013 Sep 15;12(18):3109-24. doi: 10.4161/cc.26173. Epub 2013 Aug 21.
2
Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.干性转录因子 SOX2 重编程非基因组雌激素信号增强乳腺癌细胞的肿瘤起始能力。
Cell Cycle. 2013 Nov 15;12(22):3471-7. doi: 10.4161/cc.26692. Epub 2013 Oct 4.
3
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.激活 AMP 激活的蛋白激酶 (AMPK) 为体细胞重编程为干细胞提供了代谢障碍。
Cell Cycle. 2012 Mar 1;11(5):974-89. doi: 10.4161/cc.11.5.19450.
4
CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.CXCR2 配体和 mTOR 激活增强了人体细胞重编程为多能干细胞。
Stem Cells Dev. 2020 Feb 1;29(3):119-132. doi: 10.1089/scd.2019.0188. Epub 2020 Jan 6.
5
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.通过定义性的重编程因子从非致瘤性人乳腺上皮细胞中诱导具有癌症干细胞特性的细胞。
Oncogene. 2014 Jan 30;33(5):643-52. doi: 10.1038/onc.2012.614. Epub 2013 Jan 14.
6
Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.诱导多能干细胞模型在卵巢癌中的发展和体外特性研究。
Int J Biochem Cell Biol. 2021 Sep;138:106051. doi: 10.1016/j.biocel.2021.106051. Epub 2021 Jul 31.
7
NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.NKX3-1 对于诱导多能干细胞重编程是必需的,并且可以在小鼠和人诱导多能干细胞的诱导中替代 OCT4。
Nat Cell Biol. 2018 Aug;20(8):900-908. doi: 10.1038/s41556-018-0136-x. Epub 2018 Jul 16.
8
OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.OCT4和SOX2在重编程人类成纤维细胞过程中作为转录激活因子发挥作用。
Cell Rep. 2017 Aug 15;20(7):1585-1596. doi: 10.1016/j.celrep.2017.07.071.
9
OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.在人中间重编程干细胞通过间充质-上皮转化转变为诱导多能干细胞的过程中OCT4的活性。
Development. 2016 Jan 1;143(1):15-23. doi: 10.1242/dev.130344. Epub 2015 Dec 10.
10
Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular Reprogramming.乙型肝炎病毒 x 蛋白增加细胞中的 OCT3/4 和 MYC 并促进细胞重编程。
Cell Reprogram. 2023 Oct;25(5):224-237. doi: 10.1089/cell.2023.0055. Epub 2023 Sep 26.

引用本文的文献

1
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials.mTOR信号通路在乳腺癌干细胞(BCSCs)中的作用:机制与治疗潜力
Stem Cell Res Ther. 2025 Mar 29;16(1):156. doi: 10.1186/s13287-025-04218-4.
2
Effects of 5-azacytidine and N6-methyladenosine combination on apoptosis and stemness in human breast cancer stem cells.5-氮杂胞苷与N6-甲基腺苷联合应用对人乳腺癌干细胞凋亡及干性的影响
Mol Biol Rep. 2025 Mar 7;52(1):292. doi: 10.1007/s11033-025-10398-2.
3
Modeling high-risk Wilms tumors enables the discovery of therapeutic vulnerability.建立高危 Wilms 肿瘤模型可发现治疗弱点。
Cell Rep Med. 2024 Oct 15;5(10):101770. doi: 10.1016/j.xcrm.2024.101770. Epub 2024 Oct 4.
4
Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy.释放诱导多能干细胞在革新癌症治疗方面的潜力。
Curr Stem Cell Res Ther. 2025;20(4):360-376. doi: 10.2174/011574888X294791240408055222.
5
Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.羟甲基戊二酰辅酶 A 还原酶在乳腺癌诱导干细胞样状态中的作用。
J Cancer Res Clin Oncol. 2024 Feb 28;150(2):106. doi: 10.1007/s00432-024-05607-7.
6
Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.癌细胞与诱导多能干细胞的相互转化。
Cells. 2024 Jan 10;13(2):125. doi: 10.3390/cells13020125.
7
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.mTOR(哺乳动物雷帕霉素靶蛋白)信号通路在人类健康和疾病中的多方面作用。
Signal Transduct Target Ther. 2023 Oct 2;8(1):375. doi: 10.1038/s41392-023-01608-z.
8
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors.诱导多能干细胞在恶性实体肿瘤中的应用。
Stem Cell Rev Rep. 2023 Nov;19(8):2557-2575. doi: 10.1007/s12015-023-10633-y. Epub 2023 Sep 27.
9
Identifying Cancer Type-Specific Transcriptional Programs through Network Analysis.通过网络分析识别癌症类型特异性转录程序。
Cancers (Basel). 2023 Aug 18;15(16):4167. doi: 10.3390/cancers15164167.
10
Cancer Cell Culture: The Basics and Two-Dimensional Cultures.肿瘤细胞培养:基础与二维培养
Methods Mol Biol. 2023;2645:3-40. doi: 10.1007/978-1-0716-3056-3_1.

本文引用的文献

1
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.Sox2 通过一种依赖于 Twist1 和 Sox2 转录活性状态的机制抑制乳腺癌细胞的侵袭性。
BMC Cancer. 2013 Jul 1;13:317. doi: 10.1186/1471-2407-13-317.
2
Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.连续引入重编程因子揭示了各个因子的时间敏感性需求,以及最优重编程的连续 EMT-MET 机制。
Nat Cell Biol. 2013 Jul;15(7):829-38. doi: 10.1038/ncb2765. Epub 2013 May 26.
3
CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.CD44 整合了正常干细胞、癌症干细胞和(前)转移龛中的信号。
Exp Biol Med (Maywood). 2013 Mar;238(3):324-38. doi: 10.1177/1535370213480714.
4
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.Warburg 效应 2.0:肿瘤干细胞的代谢重编程。
Cell Cycle. 2013 Apr 15;12(8):1166-79. doi: 10.4161/cc.24479. Epub 2013 Apr 2.
5
Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.揭开肿瘤起始细胞起源和癌症发展过程中癌症代谢的奥秘。
Biochim Biophys Acta. 2013 Aug;1836(1):49-59. doi: 10.1016/j.bbcan.2013.03.001. Epub 2013 Mar 21.
6
Autophagy in stem cells.干细胞中的自噬作用。
Autophagy. 2013 Jun 1;9(6):830-49. doi: 10.4161/auto.24132. Epub 2013 Mar 13.
7
Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate.哺乳动物胚胎和成年干细胞命运中的能量代谢和能量感应途径。
J Cell Sci. 2012 Dec 1;125(Pt 23):5597-608. doi: 10.1242/jcs.114827.
8
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer.基于碳水化合物的疫苗与糖脂佐剂用于乳腺癌。
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2517-22. doi: 10.1073/pnas.1222649110. Epub 2013 Jan 25.
9
Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells.利用乳腺球体作为模型系统进行蛋白质组学研究,以鉴定乳腺癌干细胞中失调的蛋白质。
Curr Mol Med. 2013 Mar;13(3):459-63.
10
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.通过定义性的重编程因子从非致瘤性人乳腺上皮细胞中诱导具有癌症干细胞特性的细胞。
Oncogene. 2014 Jan 30;33(5):643-52. doi: 10.1038/onc.2012.614. Epub 2013 Jan 14.